诺和诺德暴跌8%,新减肥药片刚上市就遭"山寨",远程医疗公司Hims推出49美元仿制药

华尔街见闻
Feb 06

诺和诺德刚刚推出的减肥药片尚未站稳脚跟,就遭遇了一场意料之外的市场挑战。2月5日周四,诺和诺德股价重挫,此前远程医疗公司Hims & Hers Health推出了诺和诺德减肥药Wegovy片剂的仿制版本,定价仅为首月49美元,随后每月99美元,远低于诺和诺德的品牌药物149美元的起始月费。诺和诺德本希望借助新品扭转颓势,但远程医疗公司推出的低价仿制版本迅速搅乱了市场格局,引发了关于药品专利保护和...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10